David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 25,900 shares at $82.88 ($2.2M) on 2018-05-01, disclosed to the SEC on 2018-05-03.
Open-market sale of $2.2M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.88 | 10,086 | $836K | 38.9% |
| 2 | $82.88 | 10,086 | $836K | 38.9% |
| 3 | $83.56 | 2,814 | $235K | 10.9% |
| 4 | $83.56 | 2,814 | $235K | 10.9% |
| 5 | $84.35 | 100 | $8K | 0.4% |
| Total | $83.03 avg | 25,900 |
| $2.2M |
| 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |